Nilsine Partners LLC Sells 3,495 Shares of The Cigna Group (NYSE:CI)

Nilsine Partners LLC cut its holdings in The Cigna Group (NYSE:CI) by 56.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,682 shares of the health services provider’s stock after selling 3,495 shares during the period. Nilsine Partners LLC’s holdings in The Cigna Group were worth $741,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the business. International Assets Investment Management LLC lifted its holdings in shares of The Cigna Group by 49,287.7% during the third quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider’s stock worth $138,590,000 after buying an additional 399,230 shares during the last quarter. FMR LLC increased its position in The Cigna Group by 2.0% during the third quarter. FMR LLC now owns 14,230,397 shares of the health services provider’s stock worth $4,929,978,000 after acquiring an additional 279,880 shares during the period. Raymond James & Associates increased its position in The Cigna Group by 42.8% during the third quarter. Raymond James & Associates now owns 860,050 shares of the health services provider’s stock worth $297,956,000 after acquiring an additional 257,711 shares during the period. Assenagon Asset Management S.A. boosted its holdings in The Cigna Group by 68.4% in the 4th quarter. Assenagon Asset Management S.A. now owns 497,875 shares of the health services provider’s stock valued at $137,483,000 after purchasing an additional 202,161 shares during the period. Finally, World Investment Advisors LLC acquired a new stake in The Cigna Group in the 3rd quarter worth $69,972,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Price Performance

NYSE:CI opened at $302.74 on Wednesday. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The firm has a market cap of $84.21 billion, a PE ratio of 28.56, a price-to-earnings-growth ratio of 0.78 and a beta of 0.54. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company’s 50-day moving average price is $296.85 and its two-hundred day moving average price is $325.37.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, topping the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business had revenue of $63.70 billion for the quarter, compared to the consensus estimate of $59.58 billion. During the same period in the previous year, the business earned $6.77 EPS. The Cigna Group’s revenue was up 29.8% compared to the same quarter last year. On average, equities analysts anticipate that The Cigna Group will post 28.5 EPS for the current fiscal year.

Analysts Set New Price Targets

CI has been the subject of a number of research analyst reports. Piper Sandler reaffirmed an “overweight” rating and set a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft reduced their price objective on The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research report on Monday, November 4th. Stephens restated an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a research report on Friday, November 1st. Barclays raised their target price on The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Finally, Truist Financial lowered their price target on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $395.93.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.